Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Dr Koren Ariel, HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier:
NCT00736060
First received: August 14, 2008
Last updated: August 25, 2011
Last verified: August 2011

August 14, 2008
August 25, 2011
May 2008
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00736060 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With Fever
Study the Clinical and Laboratory Characteristics and the Outcome of Sickle Cell Anemia Patients Admitted to the Pediatric Ward Because of Fever as the Presenting Symptom

This study will summarized the clinical and laboratory data and the outcome of all the patients suffering from Sickle Cell Anemia (Including Sickle cell thalassemia) admitted to the pediatric ward.

The actual protocol for SCA patients admitted with fever is to obtain blood cultures and start empiric antibiotic treatment.

The study cohort included 60 SCA patients actually treated in the Pediatric Hematology Unit.

Observational
Time Perspective: Retrospective
Not Provided
Not Provided
Probability Sample

60 patients treated at the Pediatric Hematology Unit in the Ha'Emek Medical Center suffering from sickle cell anemia or sickle cell thalassemia admitted with fever as the presenting symptom.

  • Sickle Cell Anemia
  • Sickle Cell Thalassemia
Other: Observational
Summary of clinical and laboratory data
  • 1
    Sickle cell anemia
    Intervention: Other: Observational
  • 2
    Sickle cell thalassemia
    Intervention: Other: Observational
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
November 2008
Not Provided

Inclusion Criteria: All patients admitted with fever as the only presenting symptom.

Exclusion Criteria: Patients admitted with another causes related or unrelated to sickle cell disease and have also fever.

Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT00736060
0027-08-EMC
No
Dr Koren Ariel, HaEmek Medical Center, Israel
HaEmek Medical Center, Israel
Not Provided
Principal Investigator: Carina Levin, MD Pediatric Hematology Unit - Ha'Emek Medical Center - Afula - 18101 - Israel
Principal Investigator: Ilena Arshinov, MD Pediatric Dpt B - Ha'Emek Medical Center - Afula - Israel
HaEmek Medical Center, Israel
August 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP